Michael C. Barnes

Attorney & Policy Advisor

Journal Publishes Special Edition on Regulatory Responses to Opioid Poisoning Crisis

November 1, 2023

The Journal of Opioid Management (JOM) has published a special edition addressing legal and policy responses to the intertwined challenges of inadequate pain management and opioid misuse. Michael C. Barnes, Esq., Chairman of the Center for U.S. Policy, served as JOM’s Special Issue Editor.

Full story

Michael C. Barnes Follow

Health, #opioid, other drug law & policy • Entrepreneur, business advisor • @USPolicyCenter • @SequelLegal • Old Kennels🌲farm • #rescuedog dad

MCBtweets
Retweet on Twitter Michael C. Barnes Retweeted
aimedalliance Aimed Alliance @aimedalliance ·
23 Jan

CareTalk recently featured an opinion piece by Aimed Alliance counsel @MCBtweets on the unregulated CBD consumer market, calling on Congress to enact legislation empowering FDA with resources to ensure access to safe, regulated CBD products. Read it here:

Reply on Twitter 1749819072597107038 Retweet on Twitter 1749819072597107038 2 Like on Twitter 1749819072597107038 3 Twitter 1749819072597107038
mcbtweets Michael C. Barnes @mcbtweets ·
26 May 2023

Balanced article by @axios about the @USPolicyCenter citizen petition to protect people with #pain, #opioidusedisorder, #adhd, and other people who need controlled medications.

Reply on Twitter 1662151550695768070 Retweet on Twitter 1662151550695768070 Like on Twitter 1662151550695768070 2 Twitter 1662151550695768070
Retweet on Twitter Michael C. Barnes Retweeted
braeburnrx Braeburn @braeburnrx ·
23 May 2023

Breaking: FDA has approved BRIXADI (buprenorphine) Extended-Release Subcutaneous Injection (CIII). Hear from our CEO, Mike Derkacz, on this important milestone.

Learn more: http://bit.ly/3IqGzfK

See Prescribing Information including Boxed Warning: https://bit.ly/3oiMigW

Reply on Twitter 1661077674448527360 Retweet on Twitter 1661077674448527360 7 Like on Twitter 1661077674448527360 24 Twitter 1661077674448527360
Load More